Should Lilly Investors Worry About Its Rival From Within
Eli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
Learn the core crypto basics and the key holdings a beginner should own, plus tips to manage risk and start a balanced portfolio.
25,015 articlesEli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
Insider moves can tell us a lot about a stock’s near-term path. When Intuitive Machines’ CEO disclosed a $1.39 millio...
Honeywell split its aerospace unit into a new company, and the initial market reaction gave investors plenty to study...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...
A fresh take on a notable portfolio move: Kettle Hill Capital reveals a sizable Braze stake via a 747,715-share initi...
A major fund reshaped its Workiva stake in a recent SEC filing, signaling routine portfolio rebalancing rather than a...
FedEx recently spun off its FedEx Freight unit, creating two focused companies. This article explains what that move ...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...